NeurAxis, Inc. Form 8-K Summary
Reporting date: January 25, 2024 earliest reported event; the Form 8-K was signed and filed January 31, 2024. The filing concerns executive and board changes and does not report periodic financial results.
Business Context and Reporting Period
NeurAxis, Inc. is a Delaware corporation headquartered in Carmel, Indiana, with common stock traded on the NYSE American under the symbol NRXS. The company is identified as an emerging growth company.
Key Financial and Operating Metrics
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other periodic financial metrics.
- Incoming CFO Timothy R. Henrichs will receive an annual base salary of $330,000, health insurance coverage, and paid personal time off.
- The company will issue Mr. Henrichs 100,000 common shares outside its equity incentive plans as an inducement award.
- During 2023, Mr. Henrichs received $8,790 for service as a non-employee director. He was also owed approximately $20,000 in unpaid cash director fees and approximately $23,700 in common stock for director service.
Material Changes Versus the Prior Comparable Period
- Timothy R. Henrichs resigned from the Board effective February 2, 2024, in connection with his appointment as CFO. The filing states that his resignation was not due to disagreement with the company.
- John Seale resigned as CFO effective at the close of business January 30, 2024.
- The Board appointed Mr. Henrichs as CFO on January 26, 2024. His employment is scheduled to begin February 5, 2024, on an at-will basis.
- Mr. Henrichs previously chaired the Board’s Audit Committee; the filing does not specify a successor.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- No financial guidance or operating outlook was provided.
- The principal unusual item is the issuance of 100,000 common shares as an inducement award, which may result in equity dilution.
- The filing discloses outstanding compensation obligations to Mr. Henrichs for his prior director service.
- The filing states that there are no relevant family relationships, appointment arrangements with other persons, or related-party transactions requiring disclosure.
- No material litigation, contingencies, debt developments, or liquidity risks are discussed.
Important Facts for Investors to Verify
- Confirm the effective dates of Mr. Seale’s CFO resignation, Mr. Henrichs’s employment commencement, and Mr. Henrichs’s Board resignation.
- Review the terms and accounting treatment of the 100,000-share inducement award and its potential dilution.
- Verify payment or settlement of approximately $20,000 in unpaid director fees and approximately $23,700 in stock compensation owed to Mr. Henrichs.
- Review subsequent filings for the appointment of a new Audit Committee chair and any additional executive or board changes.
- Consult the company’s periodic financial filings for revenue, profitability, cash balances, debt, liquidity, and operating outlook, which are not provided in this Form 8-K.